Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 14
Issue 1
Online publication date 2013-04-25
Title Significance of IL-6 and IL-17 cytokines in diagnostics and prognosis of the metabolic syndrome
Author Takhmina Avazova, Nazira Khaitova, Adolat Ismailova
Abstract
The purpose of the research was to study diagnostic and prognostic role of some cytokines in patients with metabolic syndrome. Sixty patients with metabolic syndrome were examined in the period from 2010 to 2011. Patients were divided into groups according to body mass index (BMI). The control group consisted of 30 healthy individuals. 
We studied the significance of serum Il- 6 and Il -17 in patients with metabolic syndrome. Conducted research have shown that in patients with metabolic syndrome there are elevated IL-6 levels associated with increased BMI. Most significantly increased levels of IL-6 in patients with class 2 obesity were twice higher then patients with lower body mass, as well as patients with stage 2 of Arterial hypertension had the highest IL- 6 levels. Increase of IL-17 levels in blood serum was connected with arterial hypertension, since in patients with Stage 2 Hypertension and in the cases of the family history of hypertension the levels of IL-17 were the highest.
Citation
References
Bonora, E., Kiechl, S., Willeit, J. et al., 1998. “Prevalence of insulin resistance in metabolic disorders: The Bruneck Study,” Diabetes, Vol.47, pp.1643-649

Demidova, T., 2006. “Metabolic syndrome as a disease. Modern approaches to the therapy,” Diabetes. The Life style [Diabet.Obraz zhizni], in Russian, No.5, pp.53-54

Feliksova, L., Aleshkin, V., Anisimov, A., Afanasev, S., Rubalskiy, O., 2001. “Immunoglobulins and cytokines - perspective basis of drugs,” Doctor [Vrach], in Russian, No.8, pp.33-35

Freydlin, I., Nazarov, P., 1999. “Regulatory functions of pro-inflammatory cytokines and proteins of the acute phase,” Bulletin of the Russian Academy of Medical Sciences [Vestnik Rossiyskoy akademii medicinskih nauk], in Russian, No.5, pp.28-32

Kalashnikova, E., Kokarovtseva, S., Puhalskiy, A., 2000. “Stimulation of pro - inflammatory cytokines’ release by mononuclear cells in peripheral human blood under the influence of glucocorticosteroids,” Bulletin of the Russian Academy of Medical Sciences [Vestnik Rossiyskoy Akademii Medicinskih Nauk], in Russian, Vol.10, pp.37-44

Katz, A., Nambi, S., Mather, K. et al., 2000. “Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans,” J Clin Epidemiol Metab, Vol.85(7), pp.2402-410 

Knyazeva, L., 2005. “Pro-inflammatory cytokines and endothelial dysfunction in patients with ischemic heart diseases and diabetes mellitus second type,” Immunology [Immunologiya], in Russian, No.3, pp.175-77

Liberman, I., 2002. “Metabolic syndrome in light of evaluation and genetic regularities,” Ros. Cardiology Journal [Rossiyskiy Kardiologicheskiy Zhurnal], in Russian, No.1, pp.85-89

Rantala, A., Kauma, H. et al., 2009. “Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects,” J Int Med, Vol.245, pp.163-74

Sennikov, S., Silkov, A., Kozlov, V., 2002. “Allelic variants and isoforms of cytokines in diagnostics and ptogenesis of immunopathological conditions: Review,” Immunology [Immunologiya], in Russian, Vol.23(4), pp.243-50

Shamansurova, Z., 2006. “Metabolic syndrome, scientific publishing,”  Diabetes in Uzbekistan [Diabet v Uzbekistane], in Russian, No.3, pp.19-20

Shlyakhto, E., Krasilnikova, E., Vinnik, T., Ageeva, V., 2004. “New approaches to pathogenesis treatment of metabolic cardiovascular syndrome,” Doctor [Vrach], in Russian, No.3, pp.46-50

Zavaroni, I., Bonora, E., Pagliara, M. et al., 2009. “Risk factors for coronary artery diseases in healthy persons with hyperinsulinemia and normal glucosei tolerance,” N Engl J Med, Vol.320(11), pp.702-706

Keywords Metabolic syndrome, cytokine, metabolic immune suppression, interleukins, inflammation
DOI http://dx.doi.org/10.15208/mhsj.2013.7
Pages 40-44
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2250477
Journal Downloads
MHSJ 17020
Total users online -